Bioregenx BRGX
OTC BRGX
$0.01 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Bioregenx (BRGX) Common Equity (2021 - 2026)

Bioregenx (BRGX) posted Common Equity of -$4.5 million for Q1 2026, little changed on a QoQ basis from -$4.5 million in Q4 2025, and down 27.38% year-over-year from -$6.2 million in Q1 2025.

Analysis

Bioregenx (BRGX) Common Equity (2021 - 2026) Analysis & Trends

Bioregenx has reported Common Equity for 6 years, with the latest figure at -$4.5 million in Q1 2026.

  • On a quarterly basis, Common Equity fell 27.38% year-over-year to -$4.5 million in Q1 2026; TTM through Mar 2026 was -$4.5 million, a 27.38% decrease from a year earlier, with the FY2025 full-year figure at -$4.5 million, down 34.27% from the prior year.
  • Common Equity was -$4.5 million for Q1 2026 at Bioregenx, roughly flat from -$4.5 million in the prior quarter.
  • The five-year high for Common Equity was $15.1 million in Q1 2024, with the low at -$4.5 million in Q4 2025.
  • Average Common Equity over 5 years is $391273.8, with a median of -$2.5 million recorded in 2022.
  • The sharpest annual moves came in 2022 and 2024: Common Equity slumped 2901.09% in 2022, then jumped 724.59% in 2024.
  • Over 5 years, Common Equity stood at -$2.5 million in 2022, then rose by 18.06% to -$2.1 million in 2023, then slumped by 63.14% to -$3.4 million in 2024, then slumped by 34.27% to -$4.5 million in 2025, then gained by 0.09% to -$4.5 million in 2026.
  • The last three Common Equity figures came in at -$4.5 million (Q1 2026), -$4.5 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn 51.76 Bn
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn 18.30 Bn
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn 50.85 Bn
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn 23.99 Bn
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn 25.17 Bn
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn 10.72 Bn
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn 2.62 Bn
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn 6.59 Bn
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn 21.60 Bn
10 Bioregenx 9.72 Mn 9.67 Mn 348,288.00 -4.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.53 Mn
Dec 31, 2025 -4.54 Mn
Sep 30, 2025 -3.65 Mn
Jun 30, 2025 -3.65 Mn
Mar 31, 2025 -3.56 Mn
Dec 31, 2024 -3.38 Mn
Sep 30, 2024 13.56 Mn
Jun 30, 2024 14.22 Mn
Mar 31, 2024 15.09 Mn
Dec 31, 2023 -2.07 Mn
Sep 30, 2023 -2.80 Mn
Jun 30, 2023 -2.58 Mn
Mar 31, 2023 -2.42 Mn
Dec 31, 2022 -2.53 Mn
Sep 30, 2022 -196,007.00
Jun 30, 2022 -214,216.00
Mar 31, 2022 -101,553.00
Dec 31, 2021 -84,234.00
API Access

Bioregenx Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=BRGX&period=max&api_key=YOUR_API_KEY